Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 12, 2024Archives of Clinical Neuropsychology

A - 87 Exploring the Utility of the Montreal Cognitive Assessment to Identify Neurocognitive Deficits among Adult Patients with Sickle Cell Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

SUSara UlloaTWTiffany WongHLHua Luo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ulloa et al. (2024) studied this question.

synapsesocial.com/papers/68e58cb9b6db643587527f97https://doi.org/10.1093/arclin/acae067.101
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Montreal cognitive assessment in Brazilian adults with sickle cell disease: The burdens of poor sociocultural background2024 · 2 citations
  2. 2Evaluating the efficacy of brief neurocognitive assessments in adults and adolescents with sickle cell disease2025
  3. 3Electrophysiological and Psychological Correlates of Cognition in Adult Homozygous Sickle Cell Disease Patients2026
  4. 4Validity of the Montreal Cognitive Assessment (MoCA) as a Screening Test for Mild Cognitive Impairment (MCI) in a Cardiovascular Population2010 · 201 citations
  5. 5Validity of the <scp>MoCA</scp> as a cognitive screening tool in epilepsy: Are there implications for global care and research?2024 · 23 citations